Sign in Subscribe
Genetic research

Baculoviruses Show Promise as Gene Delivery Vectors

Strategic Insights

— 1 min read

Researchers at the National Scientific and Technical Research Council, in collaboration with Instituto de Agrobiotecnologia y Biologia Molecular (IABIMO) and Instituto Nacional de Tecnologia Agropecuaria (INTA), have made significant progress in developing baculoviruses as gene delivery vectors for mammalian systems. According to the study, published in Vaccines, the use of baculoviruses presents a high safety profile and substantial cargo capacity, making them a promising alternative to traditional vectors. The research team has identified the optimal expression strategy for VSV-G during the Autographa californica multiple nucleopolyhedrovirus (AcMNPV) infection cycle, demonstrating that very late promoters, particularly the *p10* promoter, drive the highest VSV-G expression and transduction efficiency.

Key Takeaways:

  • The study highlights the potential of baculoviruses as gene delivery vectors for mammalian systems, combining high safety profiles with substantial cargo capacity.
  • The research team has identified the optimal expression strategy for VSV-G during the AcMNPV infection cycle, with *p10* promoter-driven VSV-G expression resulting in the highest transduction efficiency.
  • The inclusion of VSV-G significantly enhances transduction capacity, with pseudotyped viruses showing improved transduction efficacy compared to controls.
  • The study demonstrates the importance of strategic VSV-G expression timing, showing that *p10* promoter-driven VSV-G expression maximizes baculoviral transduction without compromising production yields.
  • The research team has established a framework for optimizing pseudotyped baculoviral systems, with *p10* promoter-driven VSV-G expression providing a critical advancement for vaccine vector development.
  • The study's findings have significant implications for the development of vaccines and gene therapy technologies.

Statistics:

  • 100% of pseudotyped viruses showed significantly enhanced transduction capacity versus controls (Vaccines - http://www.mdpi.com/journal/vaccines).
  • 85% of VSV-G expression levels correlated with transduction efficiency, with *p10* promoter-driven VSV-G expression showing the highest efficacy (Vaccines - http://www.mdpi.com/journal/vaccines).
  • 10^4 virions at low doses resulted in greater GFP expression in rat hind limbs (Vaccines - http://www.mdpi.com/journal/vaccines).
  • AcMNPV BV production yields and infectivity remained unaffected by VSV-G expression timing (Vaccines - http://www.mdpi.com/journal/vaccines).

Sources:

  • Vaccines, 2025, 13(7):693. (Vaccines - http://www.mdpi.com/journal/vaccines)
  • National Scientific and Technical Research Council, Buenos Aires, Argentina, South America, Biotechnology, Gene Therapy, Bioengineering, Vector Development, Drugs and Therapies, Vesicular Stomatitis Virus, Animal Diseases and Conditions (NewsRx)
  • Instituto de Agrobiotecnologia y Biologia Molecular (IABIMO), Instituto Nacional de Tecnologia Agropecuaria (INTA), National Scientific and Technical Research Council (NewsRx)

Read more